Type I collagen structure, synthesis, and regulation

[1]  D. Abraham,et al.  STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiation , 2018, Molecular biology of the cell.

[2]  S. Felisbino,et al.  Hyperglycemic condition during puberty increases collagen fibers deposition in the prostatic stroma and reduces MMP-2 activity. , 2017, Biochemical and biophysical research communications.

[3]  V. Everts,et al.  Molecular pathways of cell-mediated degradation of fibrillar collagen. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[4]  L. Sangiorgi,et al.  Insight into the Pathology of a COL1A1 Signal Peptide Heterozygous Mutation Leading to Severe Osteogenesis Imperfecta , 2017, Calcified Tissue International.

[5]  G. Fields,et al.  Matrix metalloproteinase collagenolysis in health and disease. , 2017, Biochimica et biophysica acta. Molecular cell research.

[6]  A. Yokoyama,et al.  Endoplasmic reticulum oxidase 1α is critical for collagen secretion from and membrane type 1-matrix metalloproteinase levels in hepatic stellate cells , 2017, The Journal of Biological Chemistry.

[7]  J. Deng,et al.  THRAP3 interacts with and inhibits the transcriptional activity of SOX9 during chondrogenesis , 2017, Journal of Bone and Mineral Metabolism.

[8]  F. Das,et al.  PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression. , 2017, American journal of physiology. Renal physiology.

[9]  Y. Ohkawa,et al.  Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin–N-cadherin pathway after spinal cord injury , 2017, Nature Medicine.

[10]  J. Pelisek,et al.  Association of Matrix Metalloproteinase Levels with Collagen Degradation in the Context of Abdominal Aortic Aneurysm. , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  L. Myatt,et al.  Autophagic Degradation of Collagen 1A1 by Cortisol in Human Amnion Fibroblasts , 2017, Endocrinology.

[12]  H. Yao,et al.  SPARC and the N-propeptide of collagen I influence fibroblast proliferation and collagen assembly in the periodontal ligament , 2017, PloS one.

[13]  M. Chu,et al.  Fibrillar Type I Collagen Enhances the Differentiation and Proliferation of Myofibroblasts by Lowering α2β1 Integrin Expression in Cardiac Fibrosis , 2017, BioMed research international.

[14]  Haiyang Li,et al.  The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice , 2016, Hepatology.

[15]  H. Schnaper,et al.  Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. , 2016, Kidney international.

[16]  K. Boumediene,et al.  Hypoxia inducible factor 1 alpha down‐regulates type i collagen through Sp3 transcription factor in human chondrocytes , 2016, IUBMB life.

[17]  D. Schlessinger,et al.  Novel action of FOXL2 as mediator of Col1a2 gene autoregulation. , 2016, Developmental biology.

[18]  K. Kadler,et al.  Fibroblast-Derived MMP-14 Regulates Collagen Homeostasis in Adult Skin , 2016, The Journal of investigative dermatology.

[19]  S. Varma,et al.  Nanomechanics of Type I Collagen. , 2016, Biophysical journal.

[20]  Andrew P McMahon,et al.  Sp7/Osterix Is Restricted to Bone-Forming Vertebrates where It Acts as a Dlx Co-factor in Osteoblast Specification. , 2016, Developmental cell.

[21]  J. V. van Laar,et al.  IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics , 2016, Scientific Reports.

[22]  Yaowen Sun,et al.  MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway , 2016, Molecular and Cellular Biochemistry.

[23]  V. Lagente,et al.  Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells , 2016, PloS one.

[24]  J. Hamilton,et al.  OSCAR‐collagen signaling in monocytes plays a proinflammatory role and may contribute to the pathogenesis of rheumatoid arthritis , 2016, European journal of immunology.

[25]  K. Murthy,et al.  Noncanonical STAT3 Activation Regulates Excess TGF-β1 and Collagen I Expression in Muscle of Stricturing Crohn’s Disease , 2015, The Journal of Immunology.

[26]  S. V. Van Doren.  Matrix metalloproteinase interactions with collagen and elastin , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[27]  D. Abraham,et al.  Failed Degradation of JunB Contributes to Overproduction of Type I Collagen and Development of Dermal Fibrosis in Patients With Systemic Sclerosis , 2014, Arthritis & rheumatology.

[28]  C. Murphy,et al.  Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity , 2014, Nature.

[29]  S. Friedman,et al.  IL-17A Enhances the Expression of Profibrotic Genes through Upregulation of the TGF-β Receptor on Hepatic Stellate Cells in a JNK-Dependent Manner , 2014, The Journal of Immunology.

[30]  G. Stein,et al.  Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis , 2014, Genome Biology.

[31]  Joseph W Freeman,et al.  Mechanical recruitment of N- and C-crosslinks in collagen type I. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[32]  B. Stefanovic,et al.  Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5′ Stem-loop of COL1a1 and COL1a2 mRNA* , 2014, The Journal of Biological Chemistry.

[33]  K. Kadler,et al.  Nonmuscle myosin II powered transport of newly formed collagen fibrils at the plasma membrane , 2013, Proceedings of the National Academy of Sciences.

[34]  Y. Asano,et al.  Fli1 Represses Transcription of the Human α2(I) Collagen Gene by Recruitment of the HDAC1/p300 Complex , 2013, PloS one.

[35]  Marko Novinec,et al.  Cathepsin K: a unique collagenolytic cysteine peptidase , 2013, Biological chemistry.

[36]  S. Saw,et al.  Vitamin D and Its Relationship with Markers of Bone Metabolism in Healthy Asian Women , 2013, Journal of clinical laboratory analysis.

[37]  M. Kraft,et al.  Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-&bgr;1 in airway fibroblasts in asthma , 2013, European Respiratory Journal.

[38]  B. Cronstein,et al.  Adenosine A2A receptors promote collagen production by a Fli1- and CTGF-mediated mechanism , 2013, Arthritis Research & Therapy.

[39]  G. Fields.  Interstitial Collagen Catabolism* , 2013, The Journal of Biological Chemistry.

[40]  A. Dunn,et al.  Conformational dynamics accompanying the proteolytic degradation of trimeric collagen I by collagenases. , 2012, Journal of the American Chemical Society.

[41]  A. Boyde,et al.  Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice☆ , 2012, Bone.

[42]  G. G. Galli,et al.  Prdm5 Regulates Collagen Gene Transcription by Association with RNA Polymerase II in Developing Bone , 2012, PLoS genetics.

[43]  Xianzhong Xiao,et al.  MicroRNA Expression Abnormalities in Limited Cutaneous Scleroderma and Diffuse Cutaneous Scleroderma , 2012, Journal of Clinical Immunology.

[44]  K. Kadler,et al.  Stepwise proteolytic activation of type I procollagen to collagen within the secretory pathway of tendon fibroblasts in situ , 2011, The Biochemical journal.

[45]  Li Li,et al.  Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse , 2011, The Journal of Cell Biology.

[46]  R. Mason,et al.  High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1 , 2011, Molecular biology of the cell.

[47]  A. Dunn,et al.  Mechanical load induces a 100-fold increase in the rate of collagen proteolysis by MMP-1. , 2011, Journal of the American Chemical Society.

[48]  C. Cooper,et al.  Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards , 2011, Osteoporosis International.

[49]  B. Stefanovic,et al.  Nonmuscle myosin-dependent synthesis of type I collagen. , 2010, Journal of molecular biology.

[50]  Wolfgang Losert,et al.  Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian Collagenases* , 2010, The Journal of Biological Chemistry.

[51]  R. Neubert,et al.  MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type I and type III. , 2010, Biochimica et biophysica acta.

[52]  D. Cho,et al.  IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. , 2010, The Journal of investigative dermatology.

[53]  M. Marques,et al.  MMP-1 polymorphism and its relationship to pathological processes , 2009, Journal of Biosciences.

[54]  D. Abraham,et al.  JunB mediates enhancer/promoter activity of COL1A2 following TGF-β induction , 2009, Nucleic acids research.

[55]  A. Sonnenberg,et al.  MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. , 2008, Blood.

[56]  Shawn M. Sweeney,et al.  Candidate Cell and Matrix Interaction Domains on the Collagen Fibril, the Predominant Protein of Vertebrates* , 2008, Journal of Biological Chemistry.

[57]  Sheue-yann Cheng,et al.  Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter. , 2007, Endocrinology.

[58]  S. Mohan,et al.  Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. , 2007, Endocrinology.

[59]  S. Jimenez,et al.  Human Collagen Krox Up-regulates Type I Collagen Expression in Normal and Scleroderma Fibroblasts through Interaction with Sp1 and Sp3 Transcription Factors* , 2007, Journal of Biological Chemistry.

[60]  R. Baxter,et al.  Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. , 2007, Molecular endocrinology.

[61]  M. Razzaque,et al.  The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. , 2007, The Journal of endocrinology.

[62]  Aditi Gupta,et al.  Emerging role of fibroblast growth factor 23 in a bone–kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization , 2007, Current opinion in nephrology and hypertension.

[63]  G. Wagner,et al.  Scleraxis and NFATc Regulate the Expression of the Pro-α1(I) Collagen Gene in Tendon Fibroblasts* , 2007, Journal of Biological Chemistry.

[64]  F. Verrecchia,et al.  Transforming growth factor-β and fibrosis , 2007 .

[65]  L. Reneker,et al.  Type I collagen glomerulopathy: postnatal collagen deposition follows glomerular maturation. , 2007, Kidney international.

[66]  F. Glorieux,et al.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.

[67]  A. Rowan,et al.  Activity of matrix metalloproteinase‐9 against native collagen types I and III , 2007, The FEBS journal.

[68]  H. Im,et al.  EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment. , 2007, Gene.

[69]  R. Weinstein,et al.  Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. , 2006, Endocrinology.

[70]  N. Nieto.  Oxidative‐stress and IL‐6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells , 2006, Hepatology.

[71]  N. Kamatani,et al.  Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts , 2006, Proceedings of the National Academy of Sciences.

[72]  J. Christopher Fromme,et al.  Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking , 2006, Nature Genetics.

[73]  S. Ralston,et al.  Genetic regulation of bone mass and susceptibility to osteoporosis. , 2006, Genes & development.

[74]  C. O’Brien,et al.  Parathyroid Hormone Controls Receptor Activator of NF-κB Ligand Gene Expression via a Distant Transcriptional Enhancer , 2006, Molecular and Cellular Biology.

[75]  C. Rosen,et al.  Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. , 2006, Bone.

[76]  D. Reid,et al.  Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women. , 2006, The Journal of clinical endocrinology and metabolism.

[77]  George Bou-Gharios,et al.  Transcriptional regulation of the human alpha2(I) collagen gene (COL1A2), an informative model system to study fibrotic diseases. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[78]  Rebecca L. Jones,et al.  TGF-β superfamily expression and actions in the endometrium and placenta , 2006 .

[79]  J. Varga,et al.  The Early-Immediate Gene EGR-1 Is Induced by Transforming Growth Factor-β and Mediates Stimulation of Collagen Gene Expression* , 2006, Journal of Biological Chemistry.

[80]  T. Irving,et al.  Microfibrillar structure of type I collagen in situ. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Yunliang Chen,et al.  CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-β1 in Embryonic Fibroblasts* , 2006, Journal of Biological Chemistry.

[82]  Yunliang Chen,et al.  Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. , 2006, Arthritis and rheumatism.

[83]  H. Yoshioka,et al.  CREB-AP1 Protein Complexes Regulate Transcription of the Collagen XXIV Gene (Col24a1) in Osteoblasts* , 2006, Journal of Biological Chemistry.

[84]  C. Peng,et al.  Activin receptor-like kinases: structure, function and clinical implications. , 2006, Endocrine, metabolic & immune disorders drug targets.

[85]  J. V. van Meurs,et al.  Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study , 2006, PLoS medicine.

[86]  K. Flanders,et al.  Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. , 2006, Cytokine & growth factor reviews.

[87]  D. Wells,et al.  Identification of a Repressor in the First Intron of the Human α2(I) Collagen Gene (COL1A2)* , 2005, Journal of Biological Chemistry.

[88]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[89]  F. Ramirez,et al.  GATA-4 binds to an upstream element of the human alpha2(I) collagen gene (COL1A2) and inhibits transcription in fibroblasts. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[90]  H. Kiyama,et al.  Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. , 2005, Gastroenterology.

[91]  Yong Xu,et al.  Collagen α1(I) Gene (COL1A1) Is Repressed by RFX Family* , 2005, Journal of Biological Chemistry.

[92]  S. Mohan,et al.  Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. , 2005, The Journal of endocrinology.

[93]  R. Aspden,et al.  Association of COLIA1 Sp1 Alleles with Defective Bone Nodule Formation In Vitro and Abnormal Bone Mineralization In Vivo , 2005, Calcified Tissue International.

[94]  A. Díez-Pérez,et al.  In vitro functional assay of alleles and haplotypes of two COL1A1-promoter SNPs. , 2005, Bone.

[95]  K. Kadler,et al.  Procollagen trafficking, processing and fibrillogenesis , 2005, Journal of Cell Science.

[96]  F. Verrecchia,et al.  The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: role of p300/CBP , 2005, Oncogene.

[97]  S. Mohan,et al.  The multi-functional role of insulin-like growth factor binding proteins in bone , 2005, Pediatric Nephrology.

[98]  D. Abraham,et al.  Activation of Key Profibrotic Mechanisms in Transgenic Fibroblasts Expressing Kinase-deficient Type II Transforming Growth Factor-β Receptor (TβRIIΔk)* , 2005, Journal of Biological Chemistry.

[99]  D. Wells,et al.  Cooperativity between Far Upstream Enhancer and Proximal Promoter Elements of the Human α2(I) Collagen (COL1A2) Gene Instructs Tissue Specificity in Transgenic Mice* , 2004, Journal of Biological Chemistry.

[100]  V. Regitz-Zagrosek,et al.  RNA-Binding Proteins Heterogeneous Nuclear Ribonucleoprotein A1, E1, and K Are Involved in Post-Transcriptional Control of Collagen I and III Synthesis , 2004, Circulation research.

[101]  N. Kugai,et al.  Biphasic Effect of Prostaglandin E2 on Osteoclast Formation in Spleen Cell Cultures: Role of the EP2 Receptor , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[102]  C. Overall,et al.  Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP) , 2004, Journal of Biological Chemistry.

[103]  Yong Xu,et al.  Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon γ (IFN-γ)* , 2004, Journal of Biological Chemistry.

[104]  J. V. van Leeuwen,et al.  Osteoblast differentiation and control by vitamin D and vitamin D metabolites. , 2004, Current pharmaceutical design.

[105]  E. Kessler,et al.  Regulation of Collagen Deposition and Lysyl Oxidase by Tumor Necrosis Factor-α in Osteoblasts* , 2004, Journal of Biological Chemistry.

[106]  Markella Ponticos,et al.  Regulation of Collagen Type I in Vascular Smooth Muscle Cells by Competition between Nkx2.5 and δEF1/ZEB1 , 2004, Molecular and Cellular Biology.

[107]  K. Kadler,et al.  Coalignment of plasma membrane channels and protrusions (fibripositors) specifies the parallelism of tendon , 2004, The Journal of cell biology.

[108]  Hiroshi Kawaguchi,et al.  Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells. , 2004, Bone.

[109]  K. Cutroneo,et al.  How do glucocorticoids compare to oligo decoys as inhibitors of collagen synthesis and potential toxicity of these therapeutics? , 2004, Journal of cellular biochemistry.

[110]  S. Leikin,et al.  Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[111]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  Karl Kadler,et al.  Matrix loading: assembly of extracellular matrix collagen fibrils during embryogenesis. , 2004, Birth defects research. Part C, Embryo today : reviews.

[113]  Annett Skupin,et al.  Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin‐4: Analysis of the functional collagen promoter sequences , 2004, Journal of cellular physiology.

[114]  L. B. Sher,et al.  Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. , 2004, Endocrinology.

[115]  D. Abraham,et al.  Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[116]  D. Abraham,et al.  The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. , 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[117]  D. Brigstock,et al.  Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[118]  Alberto Luini,et al.  Mechanism of constitutive export from the golgi: bulk flow via the formation, protrusion, and en bloc cleavage of large trans-golgi network tubular domains. , 2003, Molecular biology of the cell.

[119]  R. Burgeson,et al.  Collagen XXIV, a Vertebrate Fibrillar Collagen with Structural Features of Invertebrate Collagens , 2003, Journal of Biological Chemistry.

[120]  D. Abraham,et al.  Constitutive Connective Tissue Growth Factor Expression in Scleroderma Fibroblasts Is Dependent on Sp1* , 2003, Journal of Biological Chemistry.

[121]  E. Schönherr,et al.  Differential roles for small leucine-rich proteoglycans in bone formation. , 2003, European cells & materials.

[122]  B. Barbeau,et al.  Regulation of procollagen I (α1) by interleukin‐4 in human bronchial fibroblasts: a possible role in airway remodelling in asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[123]  H. Yamauchi,et al.  Interferon alfa down‐regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice , 2003, Hepatology.

[124]  Y. Tomino,et al.  Involvement of p300 in TGF-β/Smad-Pathway-Mediated α2(I) Collagen Expression in Mouse Mesangial Cells , 2003, Nephron Experimental Nephrology.

[125]  R. Poulsom,et al.  A Novel and Highly Conserved Collagen (proα1(XXVII)) with a Unique Expression Pattern and Unusual Molecular Characteristics Establishes a New Clade within the Vertebrate Fibrillar Collagen Family* , 2003, Journal of Biological Chemistry.

[126]  D. Abraham,et al.  Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice* , 2003, Journal of Biological Chemistry.

[127]  B. Yoon,et al.  Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development , 2003, Development.

[128]  V. Ambros.  MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.

[129]  S. Ralston,et al.  Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. , 2003, Bone.

[130]  C. Dodd,et al.  Light and X-ray Scattering Show Decorin to Be a Dimer in Solution* , 2003, The Journal of Biological Chemistry.

[131]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[132]  D. Abraham,et al.  Connective Tissue Growth Factor Gene Regulation , 2003, The Journal of Biological Chemistry.

[133]  J. Bonifacino,et al.  Morphology and dynamics of clathrin/GGA1-coated carriers budding from the trans-Golgi network. , 2003, Molecular biology of the cell.

[134]  L. Donahue,et al.  Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. , 2003, Endocrinology.

[135]  M. Takigawa,et al.  Role of CTGF/HCS24/ecogenin in skeletal growth control , 2003, Journal of cellular physiology.

[136]  P. Byers,et al.  Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[137]  Y. Inagaki,et al.  Y-box-binding Protein YB-1 Mediates Transcriptional Repression of Human α2(I) Collagen Gene Expression by Interferon-γ* , 2003, The Journal of Biological Chemistry.

[138]  D. Brenner,et al.  DNase I–hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells , 2003 .

[139]  Justin P. Annes,et al.  Making sense of latent TGFβ activation , 2003, Journal of Cell Science.

[140]  D. Brenner,et al.  5′ Stem-Loop of Collagen α1(I) mRNA Inhibits Translationin Vitro but Is Required for Triple Helical Collagen Synthesis in Vivo* , 2003, The Journal of Biological Chemistry.

[141]  A. Veis,et al.  Electrostatic Interactions Lead to the Formation of Asymmetric Collagen-Phosphophoryn Aggregates , 2003, Connective tissue research.

[142]  M. Matzuk,et al.  Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily , 2002 .

[143]  K. Miyazono,et al.  Two major Smad pathways in TGF‐β superfamily signalling , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[144]  F. Martin,et al.  The Role of p42/44 MAPK and Protein Kinase B in Connective Tissue Growth Factor Induced Extracellular Matrix Protein Production, Cell Migration, and Actin Cytoskeletal Rearrangement in Human Mesangial Cells* , 2002, The Journal of Biological Chemistry.

[145]  E. Wagner,et al.  Distinct involvement of the Jun‐N‐terminal kinase and NF‐κB pathways in the repression of the human COL1A2 gene by TNF‐α , 2002 .

[146]  D. Abraham,et al.  Prostacyclin derivatives prevent the fibrotic response to TGFβ2 by inhibiting the Ras/MEK/ERK pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[147]  S. Sa,et al.  CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. , 2002, Kidney international.

[148]  J. Otte,et al.  Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.

[149]  C. A. Miles,et al.  The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. , 2002, Journal of molecular biology.

[150]  C. Franklin,et al.  Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). , 2002, Kidney international.

[151]  M. Goldberg,et al.  Biglycan is a Repressor of Amelogenin Expression and Enamel Formation: An Emerging Hypothesis , 2002, Journal of dental research.

[152]  Barbara D. Smith,et al.  The RFX Family Interacts at the Collagen (COL1A2) Start Site and Represses Transcription* , 2002, The Journal of Biological Chemistry.

[153]  A Boyde,et al.  Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers‐Danlos‐Like Changes in Bone and Other Connective Tissues , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[154]  P. Marie,et al.  FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.

[155]  V. Sementchenko,et al.  Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β* , 2002, The Journal of Biological Chemistry.

[156]  J. Rossert,et al.  A Combination of cis-Acting Elements Is Required to Activate the Pro-α1(I) Collagen Promoter in Tendon Fibroblasts of Transgenic Mice* , 2002, The Journal of Biological Chemistry.

[157]  A. Ghosh,et al.  Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis , 2002, Experimental biology and medicine.

[158]  A. Oldberg,et al.  Abnormal collagen fibrils in tendons of biglycan/fibromodulin‐deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[159]  P. Bornstein.  The NH(2)-terminal propeptides of fibrillar collagens: highly conserved domains with poorly understood functions. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[160]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[161]  A. Díez-Pérez,et al.  Two New Single‐Nucleotide Polymorphisms in the COL1A1 Upstream Regulatory Region and Their Relationship to Bone Mineral Density , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[162]  A. Copp,et al.  Blocking endogenous FGF-2 activity prevents cranial osteogenesis. , 2002, Developmental biology.

[163]  James B. Mitchell,et al.  Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. , 2002, The American journal of pathology.

[164]  S. Shi,et al.  Age‐Related Osteoporosis in Biglycan‐Deficient Mice Is Related to Defects in Bone Marrow Stromal Cells , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[165]  S. Hormuzdi,et al.  The Globular Domain of the Proα1(I) N-Propeptide Is Not Required for Secretion, Processing by Procollagen N-Proteinase, or Fibrillogenesis of Type I Collagen in Mice* , 2002, The Journal of Biological Chemistry.

[166]  D. Rifkin,et al.  Bone abnormalities in latent TGF-β binding protein (Ltbp)-3–null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability , 2002, The Journal of cell biology.

[167]  V. Lefebvre,et al.  Regulatory mechanisms in the pathways of cartilage and bone formation. , 2001, Current opinion in cell biology.

[168]  F. Coustry,et al.  CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure. , 2001, The Journal of biological chemistry.

[169]  J. Yates,et al.  The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Is a Receptor for Connective Tissue Growth Factor* , 2001, The Journal of Biological Chemistry.

[170]  T. Osborne,et al.  YY1 Is a Positive Regulator of Transcription of theCol1a1 Gene* , 2001, The Journal of Biological Chemistry.

[171]  J. Ioannidis,et al.  Association of Collagen Iα 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: A Meta‐Analysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[172]  D. Reid,et al.  COL1A1 Sp1 Polymorphism Predicts Perimenopausal and Early Postmenopausal Spinal Bone Loss , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[173]  V. Lefebvre,et al.  L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. , 2001, Osteoarthritis and cartilage.

[174]  H. Ihn,et al.  Spl phosphorylation induced by serum stimulates the human alpha2(I) collagen gene expression. , 2001, The Journal of investigative dermatology.

[175]  G. Chisholm,et al.  Production of Human Type I Collagen in Yeast Reveals Unexpected New Insights into the Molecular Assembly of Collagen Trimers* , 2001, The Journal of Biological Chemistry.

[176]  C. Denton,et al.  Characterization of an Evolutionarily Conserved Far-upstream Enhancer in the Human α2(I) Collagen (COL1A2) Gene* , 2001, The Journal of Biological Chemistry.

[177]  P. Jackers,et al.  Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[178]  A. Roberts,et al.  Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner , 2001, Oncogene.

[179]  D. Reid,et al.  Association Between COLIA1 Sp1 Alleles and Femoral Neck Geometry , 2001, Calcified Tissue International.

[180]  S. Sa,et al.  CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling* , 2001, The Journal of Biological Chemistry.

[181]  A. Ghosh,et al.  Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. , 2001, The Journal of biological chemistry.

[182]  R M Aspden,et al.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. , 2001, The Journal of clinical investigation.

[183]  C. Glackin,et al.  Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor‐2 in MC3T3‐E1 osteoblast‐like cells , 2001, Journal of cellular biochemistry.

[184]  G. Karsenty,et al.  Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen Genes* , 2001, The Journal of Biological Chemistry.

[185]  H. Schnaper,et al.  Sp1 and Smad Proteins Cooperate to Mediate Transforming Growth Factor-β1-induced α2(I) Collagen Expression in Human Glomerular Mesangial Cells* , 2001, The Journal of Biological Chemistry.

[186]  T. Sugimoto,et al.  Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. , 2001, Biochemical and biophysical research communications.

[187]  C. Denton,et al.  Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice. , 2001, Arthritis and rheumatism.

[188]  P. Byers.  Folding defects in fibrillar collagens. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[189]  K. Kivirikko,et al.  Collagens and collagen-related diseases , 2001, Annals of medicine.

[190]  J. Ou,et al.  Synergistic Cooperation between Sp1 and Smad3/Smad4 Mediates Transforming Growth Factor β1 Stimulation of α2(I)-Collagen (COL1A2) Transcription* , 2000, The Journal of Biological Chemistry.

[191]  R. Gershoni-baruch,et al.  Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease , 2000, Nature Genetics.

[192]  Kozo Nakamura,et al.  Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase* , 2000, The Journal of Biological Chemistry.

[193]  H. Woitge,et al.  Calvariae from Fetal Mice with a Disrupted Igf1 Gene Have Reduced Rates of Collagen Synthesis but Maintain Responsiveness to Glucocorticoids , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[194]  S. Jimenez,et al.  CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. , 2000, Arthritis and rheumatism.

[195]  A. Atfi,et al.  Tumor Necrosis Factor-α Inhibits Transforming Growth Factor-β /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation* , 2000, The Journal of Biological Chemistry.

[196]  S. Itohara,et al.  Embryonic Lethality of Molecular Chaperone Hsp47 Knockout Mice Is Associated with Defects in Collagen Biosynthesis , 2000, The Journal of cell biology.

[197]  L. Ala‐Kokko,et al.  Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. , 2000, The Journal of biological chemistry.

[198]  Naoyuki Taniguchi,et al.  Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease , 2000, Nature Genetics.

[199]  B. Stefanovic,et al.  III. Posttranscriptional regulation of type I collagen , 2000 .

[200]  D. Pennington,et al.  Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. , 2000, Experimental cell research.

[201]  J. Mcneil,et al.  Tracking Col1a1 RNA in Osteogenesis Imperfecta , 2000, The Journal of cell biology.

[202]  L. Suen,et al.  Molecular Medicine © 2000 The Picower Institute Press Suppression of Type I Collagen Gene Expression by Prostaglandins in Fibroblasts Is Mediated at the Transcriptional Level , 2000 .

[203]  A. Ghosh,et al.  Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators , 2000, Oncogene.

[204]  A. Ludlow,et al.  Activation of Platelet-transforming Growth Factor β-1 in the Absence of Thrombospondin-1* , 2000, The Journal of Biological Chemistry.

[205]  R. Rippe,et al.  Collagen α1(I) Gene Contains an Element Responsive to Tumor Necrosis Factor-α Located in the 5' Untranslated Region of Its First Exon , 2000 .

[206]  E. Canalis,et al.  Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1-binding site. , 2000, Endocrinology.

[207]  T. Partridge,et al.  T-Cell-Dependent Fibrosis in the mdx Dystrophic Mouse , 2000, Laboratory Investigation.

[208]  J. Varga,et al.  Interaction of Smad3 with a proximal smad‐binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF‐β , 2000 .

[209]  N. Bulleid,et al.  Hsp47: a molecular chaperone that interacts with and stabilizes correctly‐folded procollagen , 2000, The EMBO journal.

[210]  A. Rivas-Estilla,et al.  Tumor necrosis factor α down‐regulates expression of the α1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ‐ and C/EBPδ‐dependent mechanism , 2000 .

[211]  D. Rice,et al.  Integration of FGF and TWIST in calvarial bone and suture development. , 2000, Development.

[212]  Kwang-Huei Lin,et al.  Molecular characterization of myocardial fibrosis during hypothyroidism: evidence for negative regulation of the pro-α1(I) collagen gene expression by thyroid hormone receptor , 2000, Molecular and Cellular Endocrinology.

[213]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[214]  J. Wrana,et al.  Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.

[215]  B. Dawson-Hughes,et al.  Associations of the Collagen Type Iα1 Sp1 Polymorphism with Five-Year Rates of Bone Loss in Older Adults , 2000, Calcified Tissue International.

[216]  B. Kream,et al.  Parathyroid hormone inhibits collagen synthesis and the activity of rat Col1a1 transgenes mainly by a cAMP‐mediated pathway in mouse calvariae , 2000, Journal of cellular biochemistry.

[217]  J. Massagué,et al.  Controlling TGF-β signaling , 2000, Genes & Development.

[218]  V. Lefebvre,et al.  Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-α* , 2000, The Journal of Biological Chemistry.

[219]  M. Olive,et al.  Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins , 2000, Molecular and Cellular Biology.

[220]  A. Schier,et al.  Nodal signalling in vertebrate development , 2000, Nature.

[221]  Roman S. Polishchuk,et al.  Correlative Light-Electron Microscopy Reveals the Tubular-Saccular Ultrastructure of Carriers Operating between Golgi Apparatus and Plasma Membrane , 2000, The Journal of cell biology.

[222]  H. Westphal,et al.  Use of the Cre/lox Recombination System to Develop a Non-lethal Knock-in Murine Model for Osteogenesis Imperfecta with an α1(I) G349C Substitution , 1999, The Journal of Biological Chemistry.

[223]  D. Brenner,et al.  NF-kappaB inhibits expression of the alpha1(I) collagen gene. , 1999, DNA and cell biology.

[224]  J. Bateman,et al.  Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. , 1999, Seminars in cell & developmental biology.

[225]  Gary R. Grotendorst,et al.  Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[226]  R. Derynck,et al.  Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. , 1999, Development.

[227]  J. Gécz,et al.  Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda , 1999, Nature Genetics.

[228]  T. Latifi,et al.  The RRM domain of MINT, a novel Msx2 binding protein, recognizes and regulates the rat osteocalcin promoter. , 1999, Biochemistry.

[229]  R. Iozzo.  The Biology of the Small Leucine-rich Proteoglycans , 1999, The Journal of Biological Chemistry.

[230]  K. Miyazono,et al.  Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. , 1999, The Journal of clinical investigation.

[231]  D. Brenner,et al.  Regulatory Role of the Conserved Stem-Loop Structure at the 5′ End of Collagen α1(I) mRNA , 1999, Molecular and Cellular Biology.

[232]  S. Hormuzdi,et al.  Mice with a targeted intronic deletion in the Col1a1 gene respond to bleomycin-induced pulmonary fibrosis with increased expression of the mutant allele. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[233]  M. Sabbieti,et al.  Parathyroid Hormone Regulates the Expression of Fibroblast Growth Factor‐2 mRNA and Fibroblast Growth Factor Receptor mRNA in Osteoblastic Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[234]  T. Wright,et al.  Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A , 1999 .

[235]  J. Varga,et al.  Negative modulation of α1(I) procollagen gene expression in human skin fibroblasts: Transcriptional inhibition by interferon‐γ , 1999 .

[236]  J. Uitto,et al.  Nuclear Factor-κB Mediates TNF-α Inhibitory Effect on α2(I) Collagen (COL1A2) Gene Transcription in Human Dermal Fibroblasts , 1999, The Journal of Immunology.

[237]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[238]  J. Lippincott-Schwartz,et al.  Kinetic Analysis of Secretory Protein Traffic and Characterization of Golgi to Plasma Membrane Transport Intermediates in Living Cells , 1998, The Journal of cell biology.

[239]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[240]  S. Goldstein,et al.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.

[241]  M. Nugent,et al.  Basic fibroblast growth factor-induced decrease in type I collagen gene transcription is mediated by B-myb. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[242]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[243]  D. Rowe,et al.  1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice. , 1998, Biochimica et biophysica acta.

[244]  R. Hynes,et al.  Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.

[245]  E. Canalis,et al.  Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in Murine Osteoblasts* , 1998, The Journal of Biological Chemistry.

[246]  R. Ardaillou,et al.  Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. , 1998, The Journal of clinical investigation.

[247]  V. Lefebvre,et al.  Chondrocyte-specific Enhancer Elements in the Col11a2Gene Resemble the Col2a1 Tissue-specific Enhancer* , 1998, The Journal of Biological Chemistry.

[248]  R. Jaenisch,et al.  A Gene-Targeting Approach Identifies a Function for the First Intron in Expression of the α1(I) Collagen Gene , 1998, Molecular and Cellular Biology.

[249]  M. Buck,et al.  TNF-α inhibits liver collagen-α1(I) gene expression through a tissue-specific regulatory region. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[250]  B. Crombrugghe,et al.  Role of the CCAAT-binding protein CBF/NF-Y in transcription. , 1998, Trends in biochemical sciences.

[251]  B. Crombrugghe,et al.  Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .

[252]  J. Uitto,et al.  A proximal element within the human α2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-α response element, mediates transcriptional repression by interferon-γ , 1998 .

[253]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[254]  S. Krane,et al.  Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. , 1997, American journal of medical genetics.

[255]  M. Cheung,et al.  Molecular cloning and chromatin structure analysis of the murine alpha1(I) collagen gene domain. , 1997, Gene.

[256]  H. Ihn,et al.  Oncostatin M Stimulates Transcription of the Human α2(I) Collagen Gene via the Sp1/Sp3-binding Site* , 1997, The Journal of Biological Chemistry.

[257]  H. Ihn,et al.  Sp3 is a transcriptional activator of the human α2(I) collagen gene , 1997 .

[258]  Gary R. Grotendorst.  Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .

[259]  Wei Hu,et al.  Sp1 Is Required for the Early Response of α2(I) Collagen to Transforming Growth Factor-β1* , 1997, The Journal of Biological Chemistry.

[260]  F. Maquart,et al.  Antagonistic Effects of Interferon-γ and Interleukin-4 on Fibroblast Cultures. , 1997 .

[261]  B. Crombrugghe,et al.  Cell-specific in vivo DNA-protein interactions at the proximal promoters of the proα1(I) and the proα2(I) collagen genes , 1997 .

[262]  E. Schönherr,et al.  Critical Role of Glutamate in a Central Leucine-rich Repeat of Decorin for Interaction with Type I Collagen* , 1997, The Journal of Biological Chemistry.

[263]  B. Brodsky,et al.  Altered collagen structure in mouse tail tendon lacking the α2(I) chain , 1997 .

[264]  T. Latifi,et al.  Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element. , 1997, Molecular endocrinology.

[265]  D. Rifkin,et al.  Latent transforming growth factor-beta: structural features and mechanisms of activation. , 1997, Kidney international.

[266]  C. Glass,et al.  Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[267]  K. Kadler,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, The Journal of cell biology.

[268]  I. Weber,et al.  Model Structure of Decorin and Implications for Collagen Fibrillogenesis* , 1996, The Journal of Biological Chemistry.

[269]  T. Bugge,et al.  Loss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen Deficiency , 1996, Cell.

[270]  A. Olsen,et al.  The transcription of human alpha 1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-alpha through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear-factorbinding sites. , 1996, The Biochemical journal.

[271]  H. Ihn,et al.  Transcriptional Regulation of the Human α2(I) Collagen Gene , 1996, The Journal of Biological Chemistry.

[272]  S. Grant,et al.  Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene , 1996, Nature Genetics.

[273]  K. Niederreither,et al.  A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice , 1996, The Journal of cell biology.

[274]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[275]  Patricia Ducy,et al.  c-Krox Binds to Several Sites in the Promoter of Both Mouse Type I Collagen Genes , 1996, The Journal of Biological Chemistry.

[276]  A. Hocking,et al.  Recombinant Decorin Glycoforms , 1996, The Journal of Biological Chemistry.

[277]  Roberto Pacifici,et al.  Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[278]  B. de Crombrugghe,et al.  Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter. , 1996, Nucleic acids research.

[279]  D. Rowe,et al.  Identification of a TAAT-containing Motif Required for High Level Expression of the COL1A1 Promoter in Differentiated Osteoblasts of Transgenic Mice* , 1996, The Journal of Biological Chemistry.

[280]  M. Buck,et al.  Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia. , 1996, The American journal of pathology.

[281]  C. McCulloch,et al.  TNF-alpha inactivation of collagen receptors: implications for fibroblast function and fibrosis. , 1996, Journal of immunology.

[282]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[283]  G. Stein,et al.  Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: Altered expression of collagenase, cell growth‐related, and mineralization‐associated genes , 1996, Journal of cellular biochemistry.

[284]  E. Schönherr,et al.  Modulation of collagen gel contraction by decorin. , 1996, Biochemical Journal.

[285]  D. Rowe,et al.  Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. , 1996, The Journal of clinical investigation.

[286]  J. Uitto,et al.  An AP-1 Binding Sequence Is Essential for Regulation of the Human 2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor- (*) , 1996, The Journal of Biological Chemistry.

[287]  B. de Crombrugghe,et al.  Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[288]  R. Derynck,et al.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype , 1996, The Journal of cell biology.

[289]  T. Takala,et al.  Pre- and Post-translational Regulation of Lysyl Oxidase by Transforming Growth Factor-β1 in Osteoblastic MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.

[290]  D. Prockop,et al.  Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age‐dependent phenotype of human osteogenesis imperfecta , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[291]  E. Canalis,et al.  Cortisol Increases Interstitial Collagenase Expression in Osteoblasts by Post-transcriptional Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[292]  K. Cutroneo,et al.  Glucocorticoids coordinately regulate type I collagen proα1 promoter activity through both the glucocorticoid and transforming growth factor β response elements: A novel mechanism of glucocorticoid regulation of eukaryotic genes , 1995, Journal of cellular biochemistry.

[293]  M. Parker,et al.  Transcriptional repression of the α1(I) collagen gene by ras is mediated in part by an intronic AP1 site , 1995, Journal of cellular biochemistry.

[294]  B. Crombrugghe,et al.  Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice , 1995, The Journal of cell biology.

[295]  E. Canalis,et al.  Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. , 1995, Endocrinology.

[296]  S. Reddy,et al.  Characterization of the mouse tartrate‐resistant acid phosphatase (trap) gene promoter , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[297]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[298]  H. Goldberg,et al.  Requirements for Transforming Growth Factor-β Regulation of the Pro-α2(I) Collagen and Plasminogen Activator Inhibitor-1 Promoters (*) , 1995, The Journal of Biological Chemistry.

[299]  M. Trojanowska,et al.  Characterization of a GC-rich Region Containing Sp1 Binding Site(s) as a Constitutive Responsive Element of the α2(I) Collagen Gene in Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.

[300]  E. Canalis,et al.  Cortisol downregulates osteoblast α1(I) procollagen mRNA by transcriptional and posttranscriptional mechanisms , 1995 .

[301]  S. Maity,et al.  Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[302]  Y. Inagaki,et al.  Overlapping Pathways Mediate the Opposing Actions of Tumor Necrosis Factor- and Transforming Growth Factor- on 2(I) Collagen Gene Transcription (*) , 1995, The Journal of Biological Chemistry.

[303]  F. Coustry,et al.  Studies on Transcription Activation by the Multimeric CCAAT-binding Factor CBF (*) , 1995, The Journal of Biological Chemistry.

[304]  J. Uitto,et al.  Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. , 1994, The Journal of clinical investigation.

[305]  D. Rowe,et al.  Analysis of regulatory regions in the COL1A1 gene responsible for 1,25‐dihydroxyvitamin D3‐mediated transcriptional repression in osteoblastic cells , 1994, Journal of cellular biochemistry.

[306]  D. Breault,et al.  Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line pyla: Structure‐activity relations and signal transduction mechanisms , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[307]  G. Karsenty,et al.  c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[308]  D. Thiebaud,et al.  Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[309]  R. Behringer,et al.  Normal long bone growth and development in type X collagen-null mice , 1994, Nature Genetics.

[310]  H. Yang,et al.  The triple-helical region of human type XIX collagen consists of multiple collagenous subdomains and exhibits limited sequence homology to alpha 1(XVI). , 1994, The Journal of biological chemistry.

[311]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[312]  Y. Inagaki,et al.  Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. , 1994, The Journal of biological chemistry.

[313]  M. Reed,et al.  Cell-specific expression of alpha 1(I) collagen-hGH minigenes in transgenic mice , 1994, The Journal of cell biology.

[314]  A. Olsen,et al.  Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1. , 1994, The Journal of biological chemistry.

[315]  A. Määttä,et al.  Nuclear and cytoplasmic α1(I) collagen mRNA‐binding proteins , 1994 .

[316]  B. Sokolov,et al.  Regulation of the alpha 1(I) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells. , 1994, The Journal of biological chemistry.

[317]  D. Rowe,et al.  Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[318]  E. Canalis,et al.  Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I. , 1993, Endocrinology.

[319]  J. Ritzenthaler,et al.  Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. , 1993, The Journal of biological chemistry.

[320]  Gary R. Grotendorst,et al.  Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.

[321]  S. Jimenez,et al.  Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. , 1993, The Journal of biological chemistry.

[322]  M. Hurley,et al.  Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. , 1993, The Journal of biological chemistry.

[323]  D. Rowe,et al.  Parathyroid hormone represses alpha 1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice. , 1993, Molecular endocrinology.

[324]  M T Davisson,et al.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[325]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[326]  P. Bornstein,et al.  Regulation of expression of the type I collagen genes. , 1993, American journal of medical genetics.

[327]  K. Niederreither,et al.  Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice , 1992, The Journal of cell biology.

[328]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[329]  H. Katai,et al.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.

[330]  G. Karsenty,et al.  Tissue-specific expression of the mouse α2(I) collagen promoter : studies in transgenic mice and in tissue culture cells , 1992 .

[331]  K. Cutroneo,et al.  Glucocorticoid and retinoid regulation of alpha‐2 type I procollagen promoter activity , 1992, Journal of cellular biochemistry.

[332]  B. Crombrugghe,et al.  Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. , 1992, The Journal of biological chemistry.

[333]  R. Timpl,et al.  Cloning and chromosomal location of human alpha 1(XVI) collagen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[334]  M. Hurley,et al.  The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae. , 1992, Endocrinology.

[335]  B. Thorp,et al.  Transforming growth factor-beta 1, -beta 2 and -beta 3 in cartilage and bone cells during endochondral ossification in the chick. , 1992, Development.

[336]  C. Alpers,et al.  The activated mesangial cell: a glomerular "myofibroblast"? , 1992, Journal of the American Society of Nephrology : JASN.

[337]  D. Rowe,et al.  Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells , 1992, The Journal of cell biology.

[338]  S. Mohan,et al.  1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. , 1991, Endocrinology.

[339]  M. E. van der Rest,et al.  Collagen family of proteins , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[340]  D. Brenner,et al.  Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter , 1991, Molecular and cellular biology.

[341]  G. Karsenty,et al.  Conservation of binding sites for regulatory factors in the coordinately expressed α1(I) and α2(I) collagen promoters , 1991 .

[342]  K. Kadler,et al.  A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures. , 1991, Biochemistry.

[343]  R. Ravazzolo,et al.  A fibroblast-specific factor binds to an upstream negative control element in the promoter of the mouse alpha 1(I) collagen gene. , 1991, The Journal of biological chemistry.

[344]  H. Kuivaniemi,et al.  Mutations in collagen genes: causes of rare and some common diseases in humans , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[345]  P. Bornstein,et al.  An upstream regulatory region mediates high-level, tissue-specific expression of the human alpha 1(I) collagen gene in transgenic mice , 1991, Molecular and cellular biology.

[346]  T. Linkhart,et al.  Differential Regulation of Insulin-Like Growth Factor-I (IGF-I) and IGF-II Release from Cultured Neonatal Mouse Calvaria by Parathyroid Hormone, Transforming Growth Factor-β, and 1,25-Dihydroxyvitamin D3* , 1991 .

[347]  D. Hartmann,et al.  Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. , 1991, The Journal of investigative dermatology.

[348]  J. Wergedal,et al.  Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitro , 1991 .

[349]  B. Crombrugghe,et al.  Purification and molecular cloning of the "A" chain of a rat heteromeric CCAAT-binding protein. Sequence identity with the yeast HAP3 transcription factor. , 1990, The Journal of biological chemistry.

[350]  J. Uitto,et al.  Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. , 1990, The Journal of clinical investigation.

[351]  D. Prockop.  Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. , 1990, The Journal of biological chemistry.

[352]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[353]  B. Crombrugghe,et al.  The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[354]  B. de Crombrugghe,et al.  Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene. , 1990, The Journal of biological chemistry.

[355]  P. Bornstein,et al.  A highly conserved intronic sequence is involved in transcriptional regulation of the alpha 1(I) collagen gene. , 1990, Cell regulation.

[356]  K. Kratochwil,et al.  Transcription of a mutant collagen I gene is a cell type and stage-specific marker for odontoblast and osteoblast differentiation. , 1990, Development.

[357]  Martine A. Collart,et al.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis , 1990, Nature.

[358]  L. Raisz,et al.  Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. , 1990, Endocrinology.

[359]  G. Russell,et al.  Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. , 1990, Endocrinology.

[360]  B. Kream,et al.  Interleukin-1 alpha and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism. , 1990, Molecular endocrinology.

[361]  D J Prockop,et al.  Assembly of Type I Collagen Fibrils de Novo by the Specific Enzymic Cleavage of pC Collagen , 1990, Annals of the New York Academy of Sciences.

[362]  J. Rosenbloom,et al.  Regulation of Human Lung Fibroblast Collagen Production by Recombinant Interleukin‐1, Tumor Necrosis Factor, and Interferon‐γ a , 1990, Annals of the New York Academy of Sciences.

[363]  G. Wesolowski,et al.  Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. , 1989, The Journal of biological chemistry.

[364]  A. Fine,et al.  The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts. , 1989, The Journal of biological chemistry.

[365]  E. Canalis,et al.  Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. , 1989, Endocrinology.

[366]  D. Rowe,et al.  Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. , 1989, Endocrinology.

[367]  P. Vassalli,et al.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis , 1989, The Journal of experimental medicine.

[368]  D. Brenner,et al.  Analysis of the collagen α(I) promoter , 1989 .

[369]  S. Jacques,et al.  The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model. , 1989, The Journal of investigative dermatology.

[370]  D. Rowe,et al.  1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. , 1989, Endocrinology.

[371]  R. Jaenisch,et al.  Retrovirus-induced insertional mutation in Mov13 mice affects collagen I expression in a tissue-specific manner , 1989, Cell.

[372]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[373]  B. Berman,et al.  Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. , 1989, The Journal of investigative dermatology.

[374]  M. Sporn,et al.  Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice , 1989, The Journal of cell biology.

[375]  P. Romano,et al.  Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. , 1988, The Journal of biological chemistry.

[376]  R. Graham,et al.  Actions of recombinant human γ-interferon and tumor necrosis factor α on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro , 1988 .

[377]  I. Damjanov,et al.  Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells. , 1988, The American journal of pathology.

[378]  G. Karsenty,et al.  Point mutations and small substitution mutations in three different upstream elements inhibit the activity of the mouse alpha 2(I) collagen promoter. , 1988, The Journal of biological chemistry.

[379]  E. Canalis,et al.  Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. , 1988, Endocrinology.

[380]  M. Montminy,et al.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB , 1988, Nature.

[381]  G. Karsenty,et al.  Selective activation of transcription by a novel CCAAT binding factor. , 1988, Science.

[382]  M. Bernard,et al.  Complete nucleotide sequence of the region encompassing the first twenty-five exons of the human pro alpha 1(I) collagen gene (COL1A1) , 1988, Gene.

[383]  E. Canalis,et al.  Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.

[384]  B. Kream,et al.  Variable effects of dexamethasone on protein synthesis in clonal rat osteosarcoma cells. , 1988, Endocrinology.

[385]  D. Brenner,et al.  Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. , 1988, The Journal of biological chemistry.

[386]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.

[387]  B. Beutler,et al.  Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. , 1988, Endocrine reviews.

[388]  P. Bornstein,et al.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[389]  S. Krane,et al.  Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. , 1987, The Journal of biological chemistry.

[390]  M L Chu,et al.  Organization of the human pro-alpha 2(I) collagen gene. , 1987, The Journal of biological chemistry.

[391]  E. Canalis.  Effects of tumor necrosis factor on bone formation in vitro. , 1987, Endocrinology.

[392]  R. Hoover,et al.  Collagen polymorphism in cultured rat kidney mesangial cells. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[393]  M. Eghbali,et al.  Differential effects of γ-interferon on collagen and fibronectin gene expression , 1987 .

[394]  P. Rossi,et al.  Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[395]  J. Trotter,et al.  The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. , 1987, Collagen and related research.

[396]  Donna D. Smith,et al.  Effects of Interferon-γ and Other Cytokines on Collagen Synthesis in Fetal Rat Bone Cultures* , 1987 .

[397]  Randall,et al.  Gamma-interferon inhibits collagen synthesis in vivo in the mouse. , 1987, The Journal of clinical investigation.

[398]  C. Avnstorp,et al.  Interleukin‐1 , 1987 .

[399]  D. Rowe,et al.  Hormonal regulation of collagen synthesis in a clonal rat osteosarcoma cell line. , 1986, Endocrinology.

[400]  K. Simons,et al.  The trans Golgi network: sorting at the exit site of the Golgi complex. , 1986, Science.

[401]  D. Cockayne,et al.  Glucocorticoids decrease the synthesis of type I procollagen mRNAs. , 1986, Biochemistry.

[402]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[403]  R. Raghow,et al.  Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts. , 1986, The Journal of biological chemistry.

[404]  N. Kurihara,et al.  Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. , 1986, Endocrinology.

[405]  T. Bringman,et al.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.

[406]  D. Rosen,et al.  Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[407]  M. Klagsbrun,et al.  Purification of cartilage-derived growth factor by heparin affinity chromatography. , 1985, The Journal of biological chemistry.

[408]  G. Barsh,et al.  DNA and chromatin structure of the human alpha 1 (I) collagen gene. , 1984, The Journal of biological chemistry.

[409]  R. Jaenisch,et al.  Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death , 1984, Cell.

[410]  J. Rosenbloom,et al.  Transcriptional control of human diploid fibroblast collagen synthesis by γ-interferon , 1984 .

[411]  K. Kivirikko,et al.  Heritable diseases of collagen. , 1984, The New England journal of medicine.

[412]  R. Jaenisch,et al.  Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[413]  D. Prockop,et al.  The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. , 1983, The Journal of biological chemistry.

[414]  E. Canalis.  Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. , 1983, Endocrinology.

[415]  D. Rowe,et al.  Regulation of collagen synthesis in fetal rat calvaria by 1,25-dihydroxyvitamin D3. , 1982, The Journal of biological chemistry.

[416]  I. Pastan,et al.  The collagen gene: Evidence for its evolutionary assembly by amplification of a DNA segment containing an exon of 54 bp , 1980, Cell.

[417]  F. Panagakos,et al.  Ultrastructural analysis of mineralized matrix from human osteoblastic cells: Effect of tumor necrosis factor-alpha , 1979, Molecular and Cellular Biochemistry.

[418]  R. Glanville,et al.  Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. , 1979, The Journal of biological chemistry.

[419]  K. Kivirikko,et al.  [Biosynthesis of collagen and its disorders]. , 1979, Duodecim; laaketieteellinen aikakauskirja.

[420]  E. Canalis,et al.  Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. , 1979, Endocrinology.

[421]  J. Uitto.  Collagen polymorphism: isolation and partial characterization of alpha 1(I)-trimer molecules in normal human skin. , 1979, Archives of biochemistry and biophysics.

[422]  S. Jimenez,et al.  Identification of collagen α1(I) trimer in embryonic chick tendons and calvaria , 1977 .

[423]  L. Moro,et al.  Identification of collagen alpha1(I) trimer and normal type I collagen in a polyoma virus-induced mouse tumor. , 1977, Archives of biochemistry and biophysics.

[424]  E. Canalis,et al.  Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin. , 1976, Endocrinology.

[425]  Bergeon Mt.  Collagen: a review. , 1967 .

[426]  Kayo Nakamura,et al.  Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression , 2017, Rheumatology.

[427]  George Bou-Gharios,et al.  Characterization of Mesenchymal-Fibroblast Cells Using the Col1a2 Promoter/Enhancer. , 2017, Methods in molecular biology.

[428]  W. Fraser,et al.  The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. , 2011, Clinical chemistry.

[429]  R. Puri,et al.  IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis , 2006, Nature Medicine.

[430]  D. Rifkin,et al.  Latent TGF-β binding proteins , 2005 .

[431]  K. Kivirikko,et al.  Collagens, modifying enzymes and their mutations in humans, flies and worms. , 2004, Trends in genetics : TIG.

[432]  B. Fiedler,et al.  Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. , 2004, Cardiovascular research.

[433]  D. Hulmes,et al.  Building collagen molecules, fibrils, and suprafibrillar structures. , 2002, Journal of structural biology.

[434]  G. Fields,et al.  Matrix metalloproteinases and collagen catabolism. , 2002, Biopolymers.

[435]  A. Hofman,et al.  RELATION OF ALLELES OF THE COLLAGEN TYPE I a 1 GENE TO BONE DENSITY AND THE RISK OF OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN , 2000 .

[436]  B. Olsen,et al.  Bone development. , 2000, Annual review of cell and developmental biology.

[437]  J. Massagué,et al.  Controlling TGF-beta signaling. , 2000, Genes & development.

[438]  B. Stefanovic,et al.  Fibrogenesis. III. Posttranscriptional regulation of type I collagen. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[439]  J C Olivo,et al.  Dual-color visualization of trans-Golgi network to plasma membrane traffic along microtubules in living cells. , 1999, Journal of cell science.

[440]  S. J. Chen,et al.  Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. , 1999, The Journal of investigative dermatology.

[441]  D. Brenner,et al.  Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. , 1999, Gene expression.

[442]  J. Uitto,et al.  Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. , 1999, Journal of immunology.

[443]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[444]  D. Brenner,et al.  Copyright © 1997, American Society for Microbiology Posttranscriptional Regulation of Collagen �1(I) mRNA in , 1997 .

[445]  H. Kuivaniemi,et al.  Mutations in fibrillar collagens (types I, II, III, and XI), fibril‐associated collagen (type IX), and network‐forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels , 1997, Human mutation.

[446]  P. Scott,et al.  Increased diameters of collagen fibrils precipitated in vitro in the presence of decorin from various connective tissues. , 1997, Connective tissue research.

[447]  B. Kream,et al.  Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice. , 1997, Bone.

[448]  S. Jimenez,et al.  Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms. , 1997, The international journal of biochemistry & cell biology.

[449]  E. Leroy,et al.  Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. , 1997, The Journal of rheumatology.

[450]  A. Boskey,et al.  The role of type X collagen in endochondral ossification as deduced by Fourier transform infrared microscopy analysis. , 1996, Connective tissue research.

[451]  B. Berman,et al.  Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. , 1995, The Journal of investigative dermatology.

[452]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[453]  B. Kream,et al.  Prostaglandin E2 inhibits alpha 1(I)procollagen gene transcription and promoter activity in the immortalized rat osteoblastic clonal cell line Py1a. , 1993, Molecular endocrinology.

[454]  P. Bornstein,et al.  Elements in the first intron of the alpha 1(I) collagen gene interact with Sp1 to regulate gene expression. , 1992, Gene expression.

[455]  G. Karsenty,et al.  Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells. , 1992, The Journal of biological chemistry.

[456]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[457]  E. Bonucci,et al.  Bone loss in response to long-term glucocorticoid therapy. , 1990, Bone and mineral.

[458]  E. Vuorio,et al.  The family of collagen genes. , 1990, Annual review of biochemistry.

[459]  S. Marx,et al.  Inhibitory effects of tumor necrosis factor-α and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8) , 1989 .

[460]  E. Canalis,et al.  Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. , 1989, Endocrinology.

[461]  H. T. Kim,et al.  1,25-Dihydroxyvitamin D3 interaction with dexamethasone and retinoic acid: effects on procollagen messenger ribonucleic acid levels in rat osteoblast-like cells. , 1989, Molecular endocrinology.

[462]  M. Eghbali,et al.  Differential effects of gamma-interferon on collagen and fibronectin gene expression. , 1987, The Journal of biological chemistry.

[463]  J. Myers,et al.  Human proα1(I) collagen gene structure reveals evolutionary conservation of a pattern of introns and exons , 1984, Nature.

[464]  M. Bergeon.  Collagen: a review. , 1967, The Journal of the Oklahoma State Medical Association.

[465]  M. Sabbieti,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Prostaglandins Regulate the Expression of Fibroblast Growth Factor-2 in Bone , 2022 .

[466]  Interferon (cid:1) Repression of Collagen ( COL1A2 ) Transcription Is Mediated by the RFX5 Complex* , 2022 .

[467]  B. Weston,et al.  J Am Soc Nephrol 14: 601–610, 2003 CTGF Mediates TGF-�–Induced Fibronectin Matrix Deposition by Upregulating Active �5�1 Integrin in Human , 2022 .